ClearBridge Adds Axsome Therapeutics to Small-Cap Growth Portfolio
Axsome Therapeutics joins ClearBridge’s top holdings as biotech strength drives Russell 2000 Growth Index gains in Q2 2026. ClearBridge Investments added Axsome Therapeutics (NASDAQ:AXSM) to its Small Cap Growth Strategy during Q2 2026, citing the biopharmaceutical firm’s